EGFR and cystic fibrosis: Due to the involvement of EGFR/ADAM17 paracrine and autocrine signaling in several lung disorders [109, 116], modulation of ADAM17 and EGFR activation in both COPD and CF is important, to keep the balance between anti-inflammatory processes and promotion of inflammation, and also between regeneration and excessive tissue remodeling.